3 10, 2024

Chevron, ExxonMobil, and Other Energy Stocks are Climbing on Middle East Conflict: Is it Time to Buy?

By |2024-10-03T16:19:12+00:00October 3rd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

It’s like clockwork. Anytime there’s tension in the Middle East it poses a threat to the world’s oil supply, and prices surge accordingly. That’s what we’re seeing this morning for energy stocks like Chevron (CVX) and ExxonMobil (XOM). These stocks are up nearly 6% and 7% respectively in the past week, and they’re up [...]

2 10, 2024

Nike Falls 6% on Dwindling Sales and Profits in Q1 With Weak Guidance for Q2: Is it Time to Sell NKE?

By |2024-10-02T16:58:06+00:00October 2nd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , |

Nike Inc. (NKE) is down roughly 6% Wednesday morning after the company’s earnings day Tuesday left much to be desired in the eyes of investors.  The company is still struggling to regain its footing, and after withdrawing its full-year guidance, it’s clear that the road ahead will continue to be rocky. Here’s how the [...]

1 10, 2024

Stellantis Shares Fall Amidst Forecast Cuts: While it May Be Time for Investors to Sell STLA

By |2024-10-01T17:52:27+00:00October 1st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Stellantis NV (STLA) are down 11% in the past week as the Netherlands-based automaker was forced to lower its full-year forecast as costs are climbing while production is falling. The company was originally expecting to deliver a double-digit profit percentage for the fiscal year, but now, the profit guidance has been brought [...]

30 09, 2024

Bristol Myer Stock Gets a Bump on FDA Approval for Schizophrenia Drug: Is it Time to Buy BMY?

By |2024-09-30T17:16:15+00:00September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug.  The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious [...]

30 09, 2024

Weekly Market Recap: Major Indices Manage Gains Amid Economic Data Releases

By |2024-09-30T16:26:46+00:00September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , , |

Monday: The Major Indices started the week in positive territory with investors keeping an eye on the upcoming Personal Consumption Expenditures report. The Dow rose 0.2%, the S&P 500 gained 0.3%, and the Nasdaq added 0.1%. Tuesday: China's new stimulus plan helped boost sentiment despite lower-than-expected housing data, leading to another day of gains. [...]

30 09, 2024

Investors’ Inspiration

By |2024-09-30T13:28:33+00:00September 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News, VectorVest|Tags: , , , , , , , |

Written by: Angela Akers In last week’s “Special Presentation,” Mr. Steve Chappell discussed and demonstrated the efficacy and effectiveness of the VectorVest RealTime Derby. The Derby analyzes, sorts, ranks and graphs the second-by-second performance of 169 portfolios. It tracks each portfolio’s performance from the current day’s opening bell and displays the results from the [...]

27 09, 2024

Accenture Gains Nearly 6% on Rising Demand for AI Solutions: 2 Other Reasons It’s Time to Buy ACN

By |2024-09-27T15:57:42+00:00September 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Accenture (ACN) are up just under 6% in the past week amidst hype for the company’s AI-powered performance in the fourth quarter.  The business management consultant posted adjusted earnings per share of $2.79, which matched the analyst consensus. Revenue of $16.41 billion was a 2.6% improvement year over year and ahead of [...]

26 09, 2024

Snowflake is Sinking After Announcing $2 Billion Debt Plan: Should Investors Be Concerned?

By |2024-09-26T15:58:19+00:00September 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

Shares of Snowflake Inc. (SNOW) are down roughly 2% Thursday morning, making it a 6% loss over the past month. The latest bit of downward pressure can be attributed to the company’s announcement that it will be raising $2 billion in debt. The plan involves two separate $1 billion Senior Convertible Notes, one of [...]

25 09, 2024

GM Takes a Dip After Former Bull Downgrades the Stock: 3 Things Investors Need to Know About GM

By |2024-09-25T17:25:15+00:00September 25th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Shares of General Motors Co. (GM) are down more than 5% so far Wednesday morning, making for a 7% loss over the past month. This comes on the heels of a once-bullish analyst changing his stance on the stock, downgrading it from the equivalent of buy to hold. Daniel Roeska with Bernstein moved his [...]

25 09, 2024

Will the Fed’s 0.5% rate cut lead to a soft landing for the economy?

By |2024-09-25T17:24:02+00:00September 25th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Market in Review, Stock Market News|Tags: , , , , , , , |

Last week, the Fed made a 0.5% cut to its rate. Its decision meant that one of the most highly anticipated monetary policy decisions was finally made. In fact, it came many months later than the market had thought; at the end of last year, investors believed a cut would arrive as soon as [...]

Go to Top